Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
MANGALAM DRUGS & ORGANICS LTD. - Results-Unaudited Financial Results For The Quarter Ended June 30, 2022
Download announcement < Back
05 Aug 2022
Pursuant to Regulation 30 read with part A of Schedule III of the SEBI (Listing Obligations &amp; Disclosure Requirements) Regulations, 2015 (the Listing Regulations) we wish to inform that the Board of Directors of the Company at its meeting held today i.e., August 5, 2022 inter-alia transacted the following business: 1. Considered &amp; approved the Un-Audited Financial Results for the quarter ended June 30th, 2022 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations; (Annexure A)
View all announcements for MANGALAM DRUGS & ORGANICS LTD. Source: BSE India

Mutual Fund Selector

Find the fund that is right for you

Buy? Sell? Hold?

Get the Latest Stock Tips